Navigation Links
DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
Date:1/31/2013

Dallas, TX (PRWEB) January 31, 2013

The prescription drug information center DrugRisk.com is alerting those taking the blood thinner Pradaxa of updated information on the site regarding ongoing Pradaxa bleeding lawsuits. The judge presiding over the cases recently denied a request by the maker of the drug to hide prior charges of fraud.****

“The goal of DrugRisk is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation news. By staying updated, patients can have informed discussions with their doctor and decide if they should seek legal advice,“ explains DrugRisk representative Ryan Mayer.

Reports on DrugRisk show that experts still disagree about Pradaxa bleeding risks. The FDA recently issued an update that the drug carries the same risks as warfarin.* However, the Americal College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin.**

Meanwhile, the resource center recently added a report from the Institute for Safe Medication Practices which ranks anticoagulants like Pradaxa among the highest risk outpatient drugs. The Institute also found that hemorrhage cases submitted to the FDA show bleeding from Pradaxa was nearly 5 times as likely to result in death than with warfarin.***

DrugRisk has learned that, due to the number of patients filing a Pradaxa lawsuit, they are being consolidated in a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, new information on the site shows that Judge Herndon, who is overseeing the Pradaxa litigation, signed an order on January 19th denying attempts by Pradaxa maker Boehringer Ingelheim to protect information on prior lawsuits regarding false promotion, marketing or kickbacks for their drugs.****

Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*fda.gov/Drugs/DrugSafety/ucm326580.htm
** http://content.onlinejacc.org/article.aspx?articleid=1206384
***Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****ilsd.uscourts.gov/opinions/ilsd_live.3.12.md.2385.2251290.0.pdf#search=%22pradaxa%22

Read the full story at http://www.prweb.com/releases/pradaxa-litigation/pradaxa-lawsuits/prweb10374158.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
2. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
7. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
8. Approval of Safer Alternative to Pradaxa Delayed by FDA
9. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
10. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
11. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
Breaking Medicine Technology: